0,903  0,004  CYP2C9 substrate
0,893  0,004  CYP2C19 substrate
0,849  0,004  Chemoprotective
0,847  0,010  Antiinflammatory
0,838  0,005  Respiratory analeptic
0,825  0,002  UGT1A4 substrate
0,800  0,009  Antineoplastic (breast cancer)
0,795  0,004  Skin irritative effect
0,759  0,008  Carcinogenic
0,755  0,004  Immunosuppressant
0,770  0,020  Apoptosis agonist
0,746  0,006  Analeptic
0,732  0,013  Embryotoxic
0,722  0,004  Carcinogenic, group 3
0,721  0,014  Teratogen
0,714  0,008  Sensitization
0,711  0,008  Antineoplastic (ovarian cancer)
0,681  0,006  Antipsoriatic
0,668  0,008  Proliferative diseases treatment
0,662  0,005  UDP-glucuronosyltransferase substrate
0,661  0,009  Bone diseases treatment
0,637  0,005  Antihelmintic
0,636  0,005  Antineoplastic (endocrine cancer)
0,639  0,008  Antineoplastic (pancreatic cancer)
0,628  0,001  UGT2B9 substrate
0,636  0,009  Antiparasitic
0,644  0,025  Antineoplastic (lung cancer)
0,633  0,020  Antileukemic
0,611  0,003  Expectorant
0,612  0,012  Antineoplastic (melanoma)
0,608  0,010  Antiosteoporotic
0,622  0,029  Transcription factor NF kappa B inhibitor
0,605  0,013  Chemopreventive
0,588  0,010  Nitric oxide antagonist
0,577  0,010  Antifungal
0,575  0,013  AR expression inhibitor
0,560  0,008  UGT1A1 substrate
0,548  0,003  UGT2B7 substrate
0,563  0,022  Prostate cancer treatment
0,562  0,032  TNF expression inhibitor
0,544  0,014  NOS2 expression inhibitor
0,556  0,028  Antineoplastic (colorectal cancer)
0,559  0,033  CYP3A4 substrate
0,553  0,031  GST A substrate
0,530  0,015  FMO1 substrate
0,540  0,028  Antineoplastic (colon cancer)
0,532  0,032  Antibacterial
0,508  0,010  Psychostimulant
0,514  0,019  Mutagenic
0,510  0,019  NOS3 expression inhibitor
0,506  0,031  Antipruritic, allergic
0,474  0,003  Alcohol dehydrogenase substrate
0,469  0,005  Antiviral (Influenza A)
0,469  0,005  5 Hydroxytryptamine uptake stimulant
0,469  0,008  Melanin inhibitor
0,482  0,027  Cytotoxic
0,445  0,006  Antiviral (Influenza)
0,429  0,004  Vanilloid agonist
0,453  0,028  Antineoplastic (cervical cancer)
0,449  0,032  Immunomodulator
0,420  0,008  Pneumotoxic
0,424  0,018  Antineoplastic (osteosarcoma)
0,415  0,009  Antiacne
0,411  0,007  Acaricide
0,428  0,032  Antiepileptic
0,408  0,014  Antiviral (HIV)
0,400  0,010  Antipruritic, non-allergic
0,393  0,003  Actinic keratosis treatment
0,400  0,016  Abortion inducer
0,410  0,028  Antiprotozoal (Leishmania)
0,394  0,012  Hair growth stimulant
0,407  0,029  UGT2B4 substrate
0,375  0,003  Mucolytic
0,453  0,082  Caspase 9 stimulant
0,401  0,036  Antineoplastic (glioma)
0,391  0,028  Antiglaucomic
0,383  0,024  DNA synthesis inhibitor
0,400  0,043  CYP2D6 substrate
0,374  0,027  Angiogenesis stimulant
0,384  0,044  Antineoplastic (brain cancer)
0,346  0,007  Antifungal enhancer
0,373  0,036  Antineoplastic (multiple myeloma)
0,344  0,010  Antihelmintic (Nematodes)
0,337  0,004  ATPase inhibitor
0,363  0,043  Antioxidant
0,334  0,016  Interferon gamma antagonist
0,370  0,053  ICAM1 expression inhibitor
0,333  0,018  Antineoplastic (carcinoma)
0,335  0,021  Antihypotensive
0,342  0,035  Vasodilator
0,309  0,003  Aldehyde dehydrogenase substrate
0,329  0,025  Platelet adhesion inhibitor
0,359  0,061  Cholesterol antagonist
0,329  0,031  GST M1-1 substrate
0,323  0,026  Eye irritation, high
0,343  0,053  CYP1A2 substrate
0,348  0,060  Caspase 3 stimulant
0,317  0,030  Sedative
0,297  0,010  Antineoplastic antibiotic
0,322  0,042  Antineoplastic (liver cancer)
0,295  0,017  Protein kinase stimulant
0,297  0,024  Antiviral (Herpes)
0,324  0,058  Interleukin 2 agonist
0,291  0,026  Antialcoholic
0,305  0,045  Interleukin agonist
0,320  0,063  Spasmolytic
0,285  0,030  VCAM1 expression inhibitor
0,261  0,006  Microtubule formation inhibitor
0,305  0,051  Flavin-containing monooxygenase substrate
0,294  0,044  Antineoplastic (sarcoma)
0,252  0,006  GABA C receptor antagonist
0,256  0,012  UGT2B10 substrate
0,264  0,021  Alpha-N-acetylglucosaminidase inhibitor
0,316  0,074  Immunostimulant
0,302  0,062  FMO3 substrate
0,236  0,004  Ca(v)3.1 blocker
0,281  0,049  Antimitotic
0,268  0,036  Non-steroidal antiinflammatory agent
0,311  0,081  Calcium channel activator
0,252  0,027  UGT2B15 substrate
0,321  0,101  Antineoplastic (myeloid leukemia)
0,274  0,055  Antineoplastic (glioblastoma multiforme)
0,294  0,075  CTGF expression inhibitor
0,302  0,084  Apoptosis antagonist
0,226  0,012  Choleretic
0,233  0,023  GST P1-1 substrate
0,230  0,021  Cholesterol synthesis inhibitor
0,275  0,068  Antihypercholesterolemic
0,270  0,066  Tumour necrosis factor alpha release inhibitor
0,221  0,017  Arachidonic acid antagonist
0,271  0,067  Antineoplastic (renal cancer)
0,265  0,063  Free radical scavenger
0,209  0,009  Antiviral (Influenza B)
0,233  0,034  Contraceptive
0,223  0,033  Succinate dehydrogenase inhibitor
0,274  0,084  Cardioprotectant
0,270  0,080  5 Hydroxytryptamine release stimulant
0,196  0,011  TRPA1 agonist
0,239  0,057  RNA-directed DNA polymerase inhibitor
0,185  0,004  Glycine receptor antagonist
0,194  0,014  Vanilloid 1 agonist
0,302  0,124  CYP2C19 inhibitor
0,223  0,047  Muscle relaxant
0,220  0,047  Antimutagenic
0,225  0,052  Hepatoprotectant
0,330  0,158  Antineoplastic (solid tumors)
0,185  0,018  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,253  0,089  Lipoprotein disorders treatment
0,172  0,009  T cell inhibitor
0,170  0,009  Anabolic
0,183  0,023  Adenylate cyclase stimulant
0,165  0,005  ATPase (Vacuolar H+) inhibitor
0,192  0,034  SULT1A3 substrate
0,170  0,013  Ca2+-transporting ATPase inhibitor
0,161  0,005  Glycine receptor agonist
0,164  0,010  UGT2B11 substrate
0,269  0,116  Vasodilator, coronary
0,257  0,105  Hepatic disorders treatment
0,233  0,083  Cardiovascular analeptic
0,157  0,010  Antihypermotility
0,162  0,017  Antibiotic
0,206  0,063  CYP2B6 inhibitor
0,191  0,049  Antirickettsial
0,223  0,081  Cytostatic
0,161  0,022  AMP-activated protein kinase stimulant
0,149  0,011  Ornithine decarboxylase inhibitor
0,183  0,046  Carcinogenic, group 1
0,214  0,083  Antineoplastic (lymphoma)
0,224  0,094  Hypoglycemic
0,135  0,007  Hypercalcemia treatment
0,137  0,009  Na+ K+ transporting ATPase inhibitor
0,184  0,056  Antineoplastic (bone cancer)
0,177  0,052  Antidote
0,251  0,127  Vasodilator, peripheral
0,141  0,018  Transcription factor NF kappa B stimulant
0,209  0,088  Peptidyltransferase inhibitor
0,249  0,129  Sodium/bile acid cotransporter inhibitor
0,151  0,031  Antiviral (CMV)
0,176  0,057  Uterine stimulant
0,126  0,008  5-Alpha-reductase inhibitor
0,174  0,056  Acetylcholine M1 receptor antagonist
0,148  0,032  Photosensitizer
0,160  0,045  Antieczematic
0,199  0,084  Antihypertriglyceridemic
0,195  0,081  Neurotrophic factor enhancer
0,120  0,009  Protein 50S ribosomal subunit inhibitor
0,151  0,040  Growth stimulant
0,166  0,056  Antineoplastic (squamous cell carcinoma)
0,154  0,044  Alkylator
0,133  0,026  Triose-phosphate isomerase inhibitor
0,129  0,023  CYP2A6 inhibitor
0,120  0,016  HIV-1 integrase (Strand Transfer) inhibitor
0,156  0,054  Neurotrophic factor
0,146  0,044  Autism spectrum disorders treatment
0,117  0,016  Hyperparathyroidism treatment
0,197  0,097  UGT1A6 substrate
0,111  0,010  Vanilloid 4 agonist
0,176  0,078  Diabetic retinopathy treatment
0,132  0,035  Adenylate kinase inhibitor
0,139  0,042  Ferrochelatase inhibitor
0,124  0,028  ABCA1 expression enhancer
0,169  0,074  Phospholipase C inhibitor
0,123  0,032  Androgen antagonist
0,147  0,056  Farnesoid X receptor antagonist
0,129  0,039  Estrogen antagonist
0,140  0,050  Protein-tyrosine phosphatase 1B inhibitor
0,120  0,031  Antispirochetal
0,114  0,027  Phosphofructokinase-1 inhibitor
0,118  0,031  mTOR complex 1 inhibitor
0,144  0,057  Antiseptic
0,209  0,122  Antineurogenic pain
0,090  0,003  Kainate receptor agonist
0,191  0,105  Antineoplastic (lymphocytic leukemia)
0,103  0,018  Biliverdin reductase inhibitor
0,168  0,083  Lipocortins synthesis antagonist
0,143  0,059  Skin whitener
0,217  0,133  Hypoxia-inducible factor 1 alpha inhibitor
0,117  0,033  Paget's disease treatment
0,171  0,087  Antiviral (Hepatitis)
0,248  0,165  Antiprotozoal
0,107  0,024  Estrogen receptor alpha antagonist
0,086  0,004  Parathyroid hormone antagonist
0,145  0,063  Pregnane X receptor agonist
0,173  0,092  Anesthetic general
0,087  0,008  Anesthetic inhalation
0,241  0,162  GABA C receptor rho-3 antagonist
0,135  0,056  Antiviral (Hepatitis B)
0,088  0,009  Postcoital contraceptive
0,157  0,079  Prostate disorders treatment
0,148  0,071  Genotoxic
0,123  0,046  UGT2B1 substrate
0,120  0,043  UDP-glucose 4-epimerase inhibitor
0,156  0,080  Antiviral (Hepatitis C)
0,130  0,054  Contraceptive female
0,091  0,016  Antimycoplasmal
0,100  0,024  Narcotic antagonist
0,125  0,051  Carcinogenic, group 2B
0,125  0,052  SULT1A1 substrate
0,101  0,028  Interferon agonist
0,099  0,027  GABA aminotransferase inhibitor
0,144  0,072  Cell wall synthesis inhibitor
0,161  0,090  Antineoplastic (gastric cancer)
0,166  0,094  P-glycoprotein inhibitor
0,116  0,045  GST T1-1 substrate
0,118  0,048  Antiprotozoal (Toxoplasma)
0,088  0,018  Interferon inducer
0,188  0,118  Antidiabetic symptomatic
0,195  0,126  Radioprotector
0,071  0,004  Vitamin D receptor antagonist
0,112  0,044  DNA directed RNA polymerase inhibitor
0,071  0,004  Tubulin agonist
0,085  0,019  Glutamate (mGluR6) antagonist
0,067  0,002  Vanilloid 2 agonist
0,128  0,064  Papain-like protease (SARS coronavirus) inhibitor
0,116  0,053  Electron transport complex I inhibitor
0,105  0,043  Carcinogenic, group 2A
0,083  0,021  SULT2A1 substrate
0,072  0,012  Kainate receptor antagonist
0,198  0,139  Tyrosine 3 hydroxylase inhibitor
0,079  0,021  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,067  0,008  Microtubule stabilization
0,194  0,136  UGT1A9 substrate
0,091  0,033  CDC25A inhibitor
0,145  0,087  UGT1A3 substrate
0,068  0,011  Retinoid X receptor agonist
0,140  0,083  NOS3 expression enhancer
0,067  0,010  TRPM8 blocker
0,112  0,055  GABA C receptor agonist
0,144  0,088  CF transmembrane conductance regulator agonist
0,105  0,054  Estrogen receptor beta antagonist
0,064  0,015  Adenylate cyclase 1 inhibitor
0,087  0,039  Glutamate dehydrogenase inhibitor
0,096  0,048  NADH dehydrogenase inhibitor
0,072  0,025  Calcium channel P-type blocker
0,125  0,081  Bone formation stimulant
0,069  0,025  Sphingosine kinase inhibitor
0,076  0,033  Gaucher disease treatment
0,048  0,005  CYP24 inhibitor
0,083  0,041  SULT1A2 substrate
0,189  0,149  Transcription factor STAT3 inhibitor
0,068  0,028  Acyl-CoA dehydrogenase inhibitor
0,087  0,047  Antiviral (Dengue virus)
0,084  0,044  Keratolytic
0,121  0,083  Antihemorrhagic
0,160  0,122  Antiulcerative
0,134  0,097  Protein-tyrosine phosphatase inhibitor
0,090  0,055  Antineoplastic alkaloid
0,068  0,034  Transcription factor RelA inhibitor
0,093  0,061  Antiviral (Rhinovirus)
0,085  0,053  Antiprotozoal activity enhancer
0,116  0,084  Antihyperlipoproteinemic
0,159  0,128  Hypolipemic
0,045  0,015  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,239  0,209  Antiarthritic
0,054  0,025  Glucose-6-phosphate isomerase inhibitor
0,094  0,064  Bile acid receptor antagonist
0,064  0,036  Androgen agonist
0,212  0,184  Ulceration
0,060  0,032  Pregnane X receptor antagonist
0,081  0,053  Acetylcholine nicotinic antagonist
0,105  0,078  Antitussive
0,120  0,093  Antianorexic
0,097  0,071  Glutathione S-transferase substrate
0,057  0,031  Estrogen agonist
0,067  0,041  HIV-1 integrase (3'-Processing) inhibitor
0,039  0,014  Adenosine uptake inhibitor
0,033  0,008  Prostaglandin F2 alpha agonist
0,172  0,148  Nitric-oxide synthase stimulant
0,094  0,071  Sulfotransferase substrate
0,038  0,017  HMG CoA reductase inhibitor
0,051  0,030  Antiviral (Herpesvirus 3, Human)
0,127  0,106  Antifungal (Cryptococcus)
0,050  0,029  Aldosterone antagonist
0,080  0,062  Inducible nitric-oxide synthase inhibitor
0,158  0,140  Antineoplastic enhancer
0,152  0,134  Antiparkinsonian, rigidity relieving
0,058  0,041  Lipocortins synthesis agonist
0,084  0,067  Antidote, mercury
0,109  0,092  Anesthetic
0,028  0,012  Glutamate (mGluR1) agonist
0,040  0,025  Retinoic acid alpha receptor agonist
0,019  0,004  Calcineurin inhibitor
0,053  0,038  Alpha-mannosidase inhibitor
0,036  0,022  Estrogen receptor beta agonist
0,039  0,025  Vanilloid 3 antagonist
0,196  0,182  Antithrombotic
0,091  0,079  Antiviral (Poxvirus)
0,066  0,055  Anticholelithogenic
0,053  0,042  Alcohol oxidase inhibitor
0,057  0,046  Carbamoyl phosphate synthetase inhibitor
0,176  0,166  Radiosensitizer
0,032  0,022  ATP citrate lysase inhibitor
0,021  0,011  Progesterone receptor B antagonist
0,122  0,113  Antidiarrheal
0,032  0,023  Glutamate (mGluR3) agonist
0,041  0,032  Guanylate cyclase inhibitor
0,018  0,009  Vitamin D receptor agonist
0,052  0,044  Sphingosine kinase 2 inhibitor
0,018  0,010  Telomerase stimulant
0,016  0,009  Antibiotic Macrolide-like
0,019  0,012  Alpha 2b adrenoreceptor agonist
0,065  0,059  Andropause treatment
0,051  0,045  Argininosuccinate synthase inhibitor
0,108  0,103  Cocaine dependence treatment
0,085  0,079  Creatine kinase inhibitor
0,088  0,082  GABA C receptor rho-1 antagonist
0,073  0,068  MAP kinase kinase 7 inhibitor
0,091  0,086  Toll-Like receptor 4 antagonist
0,032  0,028  Kainate receptor 2 antagonist
0,026  0,022  Retinoid X gamma receptor antagonist
0,021  0,018  Retinoic acid gamma receptor agonist
0,099  0,095  Menstruation disorders treatment
0,177  0,173  Transcription factor STAT inhibitor
0,027  0,023  RNA-directed RNA polymerase stimulant
0,005  0,002  Vitamin D-like
0,056  0,053  Ryanodine receptor antagonist
0,024  0,022  Sodium/glucose cotransporter inhibitor
0,064  0,062  Porphobilinogen synthase inhibitor
0,082  0,080  SULT1E1 substrate
0,018  0,016  Antibiotic Anthracycline-like
0,021  0,020  Retinoic acid receptor agonist
0,017  0,016  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,024  0,023  Sodium/glucose cotransporter 2 inhibitor

